Evidence map›Paper›PMID 41550335›Full record

ArticleFrontiers in plant science2025

Production of functional human galectin-1 in transplastomic tobacco and simplified recovery via batch-mode purification.

Catalina Francisca Vater, Juan Manuel Pérez Sáez, Juan Carlos Stupirski, Mora Massaro, Federico Gabriel Mirkin, Fernando Félix Bravo-Almonacid, Gabriel Adrián Rabinovich, Mauro Miguel Morgenfeld

Abstract read
In one paragraph

Article in Frontiers in plant science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Catalina Francisca Vater *Laboratorio de Biotecnología Vegetal, Instituto de Investigaciones en Ingeniería Genética y Biología Molecular "Dr. Héctor N. Torres" (INGEBI-CONICET), Ciudad Autónoma de Buenos Aires, Argentina.
Juan Manuel Pérez Sáez *Laboratorio de Glicomedicina, Programa de Glicociencias, Instituto de Biología y Medicina Experimental (IBYME-CONICET), Ciudad Autónoma de Buenos Aires, Argentina.
Juan Carlos StupirskiLaboratorio de Glicomedicina, Programa de Glicociencias, Instituto de Biología y Medicina Experimental (IBYME-CONICET), Ciudad Autónoma de Buenos Aires, Argentina.
Mora MassaroLaboratorio de Glicomedicina, Programa de Glicociencias, Instituto de Biología y Medicina Experimental (IBYME-CONICET), Ciudad Autónoma de Buenos Aires, Argentina.
Federico Gabriel MirkinLaboratorio de Biotecnología Vegetal, Instituto de Investigaciones en Ingeniería Genética y Biología Molecular "Dr. Héctor N. Torres" (INGEBI-CONICET), Ciudad Autónoma de Buenos Aires, Argentina.
Fernando Félix Bravo-AlmonacidLaboratorio de Biotecnología Vegetal, Instituto de Investigaciones en Ingeniería Genética y Biología Molecular "Dr. Héctor N. Torres" (INGEBI-CONICET), Ciudad Autónoma de Buenos Aires, Argentina.
Gabriel Adrián RabinovichFacultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Ciudad Autónoma de Buenos Aires, Argentina.
Mauro Miguel MorgenfeldLaboratorio de Biotecnología Vegetal, Instituto de Investigaciones en Ingeniería Genética y Biología Molecular "Dr. Héctor N. Torres" (INGEBI-CONICET), Ciudad Autónoma de Buenos Aires, Argentina.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Plant molecular farming has established itself as a transformative technology for the cost-effective and sustainable production of biopharmaceuticals, offering scalable solutions to meet growing global demand. Among the different stable plant expression systems, plastid-based platforms are particularly attractive due to their high recombinant protein accumulation potential, genetic stability, and reduced risk of transgene escape. Human Galectin-1 (hGAL1) is a β-galactoside-binding lectin with potent immunomodulatory properties, positioning it as a promising therapeutic candidate for autoimmune and inflammatory diseases. Preserving its native conformation and carbohydrate-binding capacity is essential to keep its biological activity, and both properties may be compromised under suboptimal expression or purification conditions. Here, we demonstrate the relevance of chloroplast transformation in

Indexed as

batch mode purificationbiopharmaceutical productionchloroplast transformationhuman galectin-1plant molecular farmingtransplastomic tobacco

Identifiers

PMID41550335
PMCPMC12808362

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.